SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO LTD revenue breakdown overview

SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO LTD revenue for the last year amounted to 5.41 B EUR, the most of which — 3.90 B EUR — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 3.87 B EUR. The greatest contribution to the revenue figure was made by China — last year it brought SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO LTD 4.01 B EUR, and the year before that — 3.98 B EUR.